Depression in Multiple Sclerosis Associated with Interferon Beta-1a (Rebif)

Minden SL Orav L Reich P. Depression in multiple sclerosis. Gen Hosp Psych 1987;9:426–34.

Klapper JA . Interferon beta treatment of multiple sclerosis. Neurol 1994;44:188.

Canadian Pharmacists Association. Compendium of pharmaceuticals and specialties 36th ed. Ottawa: Canadian Pharmacists Assoc; 2001.

Radloff LS . The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385–401.

Weissman MM Sholomskas D Pottenger M Prusoff BA Locke BZ . Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977;106:203–14.

Mohr DC Goodkin DE Likosky W Gatto N Neilly LK Griffin C , and others. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment. Mult Scler 1996;2:222–6.

Patten SB Metz LM . Interferon beta-1a and depression in relapsing-remitting multiple sclerosis: An analysis of depression data from the PRISMS clinical trial. Mult Scler 2001;7:243–8.

Musselman DL Lawson DH Gumnick JF Manatunga AK Penna S Goodkin RS , and others. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961–6.